These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9836247)

  • 1. Differential chronergy of propranolol effects on heart rate in healthy and hypertensive subjects.
    Ruiz-Vega H; Acosta-Urzua LF; Carranza-Madrigal J; Huape-Arreola MS
    Proc West Pharmacol Soc; 1998; 41():71-2. PubMed ID: 9836247
    [No Abstract]   [Full Text] [Related]  

  • 2. Practolol-propranolol. A comparison of antihypertensive effect.
    Andersson O; Berglund G
    Acta Med Scand; 1974 Dec; 196(6):479-82. PubMed ID: 4617491
    [No Abstract]   [Full Text] [Related]  

  • 3. [Various cycloergometric variables in patients with uncomplicated borderline arterial hypertension. Effect of chlorthalidone and propranolol].
    Wajngarten M; Netto MP; Godoy M; Solórzano JA; Barretto AC; Mady C; Macruz R; Pileggi F
    Arq Bras Cardiol; 1982 Sep; 39(3):163-7. PubMed ID: 7186360
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of propranolol effects as a function of its chronergy and circadian variation of blood pressure.
    Ruiz-Vega H; Acosta-Urzua LF; Carranza-Madrigal J; Huape-Arreola MS
    Proc West Pharmacol Soc; 1998; 41():69-70. PubMed ID: 9836246
    [No Abstract]   [Full Text] [Related]  

  • 5. [Structure of the sinus dysfunction in hypertensive patients].
    Tuev AV; Poteshkina NG; Grigoriadi NE
    Ter Arkh; 2004; 76(8):36-8. PubMed ID: 15471394
    [No Abstract]   [Full Text] [Related]  

  • 6. [The influence of a long-acting formulation of propranolol on the circadian rhythm of heart rate in elderly patients with essential hypertension].
    Shimamoto Y; Nakamura H; Shimamoto H; Sakata S
    Kokyu To Junkan; 1988 Nov; 36(11):1205-10. PubMed ID: 3247537
    [No Abstract]   [Full Text] [Related]  

  • 7. Consequence of exercise on the cardiovascular effects of l-propranolol in spontaneously hypertensive rats.
    Brynne L; Paalzow LK; Karlsson MO
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1201-8. PubMed ID: 10945878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of propranolol and I.C.I. 50,172 on isoprenaline-induced increase in skin temperature in man.
    Harrison J; Turner P
    Br J Pharmacol; 1969 May; 36(1):177P-178P. PubMed ID: 5768091
    [No Abstract]   [Full Text] [Related]  

  • 9. Part played by bradycardia in action of propranolol.
    Hamer J; Fleming J; Shinebourne E
    Br Heart J; 1968 Nov; 30(6):873. PubMed ID: 5719006
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta adrenergic blockade and circulating eosinophils.
    Koch-Weser J
    Arch Intern Med; 1968 Mar; 121(3):255-8. PubMed ID: 4868283
    [No Abstract]   [Full Text] [Related]  

  • 11. I am a 46-year-old man with hypertension. I recently started taking Inderal for my blood pressure. I feel fine and my pressure is way down, but I can no longer get my pulse up when I work out on my treadmill or bike. Does that mean I won't benefit from exercise anymore?
    Simon HB
    Harv Mens Health Watch; 1999 Oct; 4(3):8. PubMed ID: 10576938
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
    Wójcicki J; Jaroszynska M; Droździk M; Pawlik A; Gawrońska-Szklarz B; Sterna R
    Biopharm Drug Dispos; 2003 Jul; 24(5):211-8. PubMed ID: 12784321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing heart rate variability power spectral analysis during controlled breathing in patients with chronic heart failure or hypertension and in healthy normotensive subjects.
    Piccirillo G; Magrì D; Naso C; di Carlo S; MoisE A; De Laurentis T; Torrini A; Matera S; Nocco M
    Clin Sci (Lond); 2004 Aug; 107(2):183-90. PubMed ID: 15046616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian heart rate variability in patients with primary arterial hypertension.
    Kolasińska-Kloch W; Furgała A; Banach T; Laskiewicz J; Thor PJ
    Przegl Lek; 2002; 59(9):752-5. PubMed ID: 12632903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of propranolol in patients with alcohol dependence during withdrawal.
    Kähkönen S; Bondarenko B; Lipsanen J; Zvartau E
    Int J Psychophysiol; 2007 Dec; 66(3):225-30. PubMed ID: 17761330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rate of the morning heart rate rising as an indicator of circadian rhythm disturbances in patients with hypertensive disease].
    Snezhitskiĭ VA; Pelesa ES
    Klin Med (Mosk); 2009; 87(4):28-32. PubMed ID: 19514317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of heart rate variability in hypertensive patients before and after treatment with angiotensin II-converting enzyme inhibitors.
    Menezes Ada S; Moreira HG; Daher MT
    Arq Bras Cardiol; 2004 Aug; 83(2):169-72; 165-8. PubMed ID: 15322659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hydrochlorothiazide and propranolol treatment on chylomicron metabolism in hypertensive objects.
    Bernik MM; Heimann JC; Nakandakare ER; Cazita PM; Nunes VS; Rocha JC; Neves MQ; Quintão EC
    Can J Physiol Pharmacol; 2005 Jul; 83(7):617-23. PubMed ID: 16091787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The psychophysiology of borderline hypertension.
    Julius S
    Res Publ Assoc Res Nerv Ment Dis; 1981; 59():293-303. PubMed ID: 7455335
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of the association of quinidine with propranolol on the isolated rabbit heart.
    Bertaccini G; Impicciatore M; Visioli O; Malagnino G
    Farmaco Sci; 1968 Jul; 23(7):711-6. PubMed ID: 5670113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.